Published in Diabetes Care on September 29, 2014
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes. Korean J Intern Med (2014) 0.88
Neurofunctional topography of the human hippocampus. Hum Brain Mapp (2015) 0.84
Diabetic aggravation of stroke and animal models. Exp Neurol (2017) 0.75
Piracetam Facilitates the Anti-Amnesic but not Anti-Diabetic Activity of Metformin in Experimentally Induced Type-2 Diabetic Encephalopathic Rats. Cell Mol Neurobiol (2016) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2010) 7.93
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA (2009) 5.75
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med (1993) 5.61
Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med (2007) 4.65
The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol (2010) 4.59
The barrier of hypoglycemia in diabetes. Diabetes (2008) 4.50
Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia (2007) 4.41
Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia (2005) 4.19
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care (2013) 3.89
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 3.49
An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr (1998) 3.49
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol (2011) 3.25
Correlation between rates of brain atrophy and cognitive decline in AD. Neurology (1999) 3.07
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI. Neurology (2009) 2.84
Brain imaging in patients with diabetes: a systematic review. Diabetes Care (2006) 2.39
Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol (2008) 2.25
Frequency and risk factors of severe hypoglycaemia in insulin-treated Type 2 diabetes: a cross-sectional survey. Diabet Med (2006) 1.86
The Action to Control Cardiovascular Risk in Diabetes Memory in Diabetes Study (ACCORD-MIND): rationale, design, and methods. Am J Cardiol (2007) 1.85
Hypoglycemia, functional brain failure, and brain death. J Clin Invest (2007) 1.77
Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology (2008) 1.56
Hypoglycaemia and cognitive function. Diabetes Obes Metab (2005) 1.53
Reversible hyperintensity lesion on diffusion-weighted MRI in hypoglycemic coma. Neurology (2004) 1.47
Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke (1996) 1.31
Reversible focal splenial lesions. Neuroradiology (2007) 1.27
Diffusion MR imaging of hypoglycemic encephalopathy. AJNR Am J Neuroradiol (2009) 1.26
Neurocognitive functioning in children diagnosed with diabetes before age 10 years. J Diabetes Complications (1999) 1.20
Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia (1990) 1.19
Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke (2005) 1.16
Case report: hypoglycemia and diffusion-weighted imaging. J Comput Assist Tomogr (2003) 1.12
Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med (1995) 0.99
Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia. J Clin Invest (2013) 0.97
Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia (2008) 0.95
Pre-MRI procedure screening: recommendations and safety considerations for biomedical implants and devices. J Magn Reson Imaging (2000) 0.94
Diffusion-weighted MR imaging in early diagnosis and prognosis of hypoglycemia. AJNR Am J Neuroradiol (2006) 0.92
Reversible reduction of apparent diffusion coefficient values in bilateral internal capsules in transient hypoglycemia-induced hemiparesis. AJNR Am J Neuroradiol (2006) 0.91
Time related changes in reversible MRI findings after prolonged hypoglycemia. Clin Neurol Neurosurg (2006) 0.81
Reversible injury of internal capsule and splenium in a patient with transient hypoglycemic hemiparesis. Cerebrovasc Dis (2006) 0.80
American Diabetes Association research symposium: diabetes and the brain. Diabetes (2012) 0.79
Rapid improvement of diffusion-weighted imaging abnormalities after glucose infusion in hypoglycaemic coma. BMJ Case Rep (2009) 0.76
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care (2014) 2.20
Brain and White Matter Hyperintensity Volumes After 10 Years of Random Assignment to Lifestyle Intervention. Diabetes Care (2016) 0.83
Review: inhaled insulin provides better glycemic control than oral hypoglycemic agents but not better than subcutaneous insulin. ACP J Club (2007) 0.75
Intensive insulin therapy reduced cardiovascular disease in type 1 diabetes. ACP J Club (2006) 0.75
Review: inhaled insulin provided better glycaemic control than oral hypoglycaemic agents but not subcutaneous insulin. Evid Based Med (2007) 0.75
Enalapril reduced the risk for developing new-onset diabetes in left ventricular dysfunction. ACP J Club (2003) 0.75